(Q45763280)

15 December 2017

title

Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants (English)

1 reference

15 December 2017

main subject

Vaccinia virus

object named as

vaccinia virus

1 reference

5

Hurwitz JL

1 reference

15 December 2017

author name string

Rencher SD

1

1 reference

15 December 2017

Lockey TD

2

1 reference

15 December 2017

Srinivas RV

3

1 reference

15 December 2017

Owens RJ

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

15

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

265-272

1 reference

15 December 2017

HIV infection in vaccinated volunteers.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Non-producer human cells induced by murine sarcoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

AIDS vaccines. Are researchers racing toward success, or crawling?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Basic study and laboratory standardization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary subcutaneous vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary subcutaneous vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Summary

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900185-5

7 January 2021

10.1016/S0264-410X(96)00185-5

Identifiers

DOI

1 reference

15 December 2017

release_tlcxukhvibbgnp77qcivqy5ysm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tlcxukhvibbgnp77qcivqy5ysm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9139484

1 reference

15 December 2017